Focused HCP discussion and proactive education on relapse identification and management improves patient reporting and timely treatment of MS relapse
CMSC Annual Meeting, 2017
Authors: R.W. Waltrip II, N. Mahler, A. Ahsan, and L.B. Herbert
Partnering with Mallinckrodt Pharmaceuticals, this abstract was published at the CMSC Annual Meeting, showcasing data from Health Union’s Multiple Sclerosis In America 2017, a syndicated research study.
